| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Hydrocodone bitartrate |
Is a |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone measurement |
Component |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorpheniramine maleate + hydrocodone bitartrate + phenylephrine hydrochloride 2mg/2.5mg/5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone bitartrate 10 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen + hydrocodone bitartrate 500mg/7.5mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 556 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone bitartrate 7.5 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone bitartrate + potassium guaiacolsulfonate 5mg/300mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing hydrocodone bitartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone bitartrate 10 mg and paracetamol 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone bitartrate 2.5 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorphenamine polistirex and hydrocodone polistirex |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone polistirex 10mg/chlorpheniremine polistirex 8mg per 5mL oral m/r suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocodone- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorphenamine and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine- and hydrocodone- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing hydrocodone and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocodone polistirex 20mg/chlorpheniremine polistirex 4mg per 5mL oral m/r suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Measurement of hydrocodone in urine (procedure) |
Component |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hydrocodone polistirex |
Is a |
False |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone bitartrate |
Is modification of (attribute) |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hydrocodone polistirex |
Is modification of (attribute) |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing aspirin and hydrocodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing hydrocodone and ibuprofen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing hydrocodone and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing hydrocodone and ibuprofen in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing hydrocodone and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing aspirin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocodone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing homatropine and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing homatropine and hydrocodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing hydrocodone and potassium guaiacolsulfonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing brompheniramine and guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing brompheniramine and guaifenesin and hydrocodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brompheniramine and guaifenesin and hydrocodone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only chlorphenamine and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only chlorphenamine and hydrocodone and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocodone and ibuprofen only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only hydrocodone and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocodone and phenylpropanolamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocodone and potassium guaiacolsulfonate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Homatropine and hydrocodone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Guaifenesin and hydrocodone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only hydrocodone and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brompheniramine and guaifenesin and hydrocodone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocodone and ibuprofen only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only aspirin and hydrocodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Homatropine and hydrocodone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocodone and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hydrocodone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Measurement of hydrocodone in urine (procedure) |
Component |
True |
Hydrocodone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]